System does a better job of indicating which patients with acute chest pain could experience adverse outcomes.
When it comes to predicting major cardiac events, the Coronary Artery Disease Reporting and Data System (CAD-RADS) does a better job with patients who have chest pain than coronary artery calcium (CAC) scoring.
In an article published July 19 in Radiology, investigators from South Korea showed that the CAD-RADS system, introduced in 2016, performs well in accurately predicting these events when acute pain is present. The system has already been shown to outperform CAC scoring for more stable chest pain.
Their work shows relying on CAD-RADS can provide benefit to patients who could be facing major adverse cardiovascular events (MACE).
“The Coronary Artery Disease Reporting and Data System category had an incremental prognostic value compared with clinical risk factors and coronary artery calcium score to predict future major adverse cardiovascular events in patients with acute chest pain presenting to the emergency department,” said the team led by Ji Won Lee, M.D., Ph.D., from the Pusan National University radiology department. “Our results showed that a higher CACS, higher CAD-RADS categories, and presence of high-risk plaque are associated with future MACE risk after adjusting for clinical risk factors.”
For their study, Lee’s team assessed CCTA exams from 1,492 patients who presented to four emergency department between January 2010 and December 2017. During that time, they determined that CAD-RADS augmented risk stratification more than clinical risk factors did with or without CAC scoring. Their findings also showed that CAD-RADS and existing high-risk plaque were independent MACE predictors.
Specifically, during 31.5 months of follow-up, 103 patients (7 percent) experienced MACEs. The team’s analysis revealed that having moderate-to-severe CACS was associated with MACE after adjusting for clinical risk factors, as were CAD-RADS categories 3, 4, or 5. Ultimately, the C statistics showed that CAD-RADS risk stratification improvement was 0.85 over clinical factors alone (0.63) or in combination with CAC scoring (0.76).
In an accompanying editorial, Rozemarijn Vliegenthart, M.D., Ph.D., a radiologist at the University Medical Center Gröningen in The Netherlands, said this study is the first to her knowledge that takes an in-depth look at prognostic value that CAD-RADS brings to evaluating patients with acute chest pain.
She noted that these findings underscore ongoing efforts that show the system can help radiologists better communicate CT findings to referring providers. In addition, she pointed out that the system could help with quality-of-care standardization, ultimately improving patient outcomes.
“This valuable study…gives a first glimpse, but a defining and consequential one, of the value that a standardized CCTA reporting system, including its additional CAD features, can have in patients with acute chest pain,” she said. “CAD-RADS helps to standardize quality of care and, moreover, may improve the outcome in patients with acute chest pain across emergency departments. Although it may still be, as to be expected in such a study, a preliminary expectation, in my opinion, it is a big step in the right direction.”
For more coverage based on industry expert insights and research, subscribe to the Diagnostic Imaging e-Newsletter here.
Study Examines CT-Based AI Detection of Incidental Abdominal Aortic Aneurysms
April 29th 2025The AI software Viz AAA offered a sensitivity of 87.5 percent in detecting abdominal aortic aneurysms on contrast-enhanced CT, according to new retrospective research presented at the American Roentgen Ray Society (ARRS) conference.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
What is the Best Use of AI in CT Lung Cancer Screening?
April 18th 2025In comparison to radiologist assessment, the use of AI to pre-screen patients with low-dose CT lung cancer screening provided a 12 percent reduction in mean interpretation time with a slight increase in specificity and a slight decrease in the recall rate, according to new research.
Meta-Analysis Shows Merits of AI with CTA Detection of Coronary Artery Stenosis and Calcified Plaque
April 16th 2025Artificial intelligence demonstrated higher AUC, sensitivity, and specificity than radiologists for detecting coronary artery stenosis > 50 percent on computed tomography angiography (CTA), according to a new 17-study meta-analysis.